Navigation Links
Doctors Outraged Over Growth Hormone Controversy

Two anti-aging preventative medicine doctors say they are outraged over recent media coverage about their advocacy of prescribing human growth hormone to treat a hormone deficiency often associated with aging.

DAYTONA BEACH, Fla., April 27, 2007 /PRNewswire/ -- The adult use of human growth hormone (HGH) was at the center of a recent New York Times article about the founders of the American Academy of Anti-Aging Medicine (http://worldhealth.net/), Dr. Ronald Klatz M.D. and Dr. Robert Goldman M.D.

Writing for the New York Times, Duff Wilson reported the two physicians to be promoting the controversial hormone as an aid to extending human life span, despite claimed reports of serious side effects.

In comments to Fintan Dunne, editor of health Web site http://MyLongLife.com, the two physicians say they are outraged by a slew of recent negative media coverage on the topic. MyLongLife.com has a special report with an in-depth examination of the HGH issue and the role of established medical and pharmaceutical interests.

"There is a hidden battle going on for your right to a long, vital and healthy life," says Editor, Fintan Dunne. "Beneath the surface of this story there are hundreds of billions of dollars at stake, along with the future of medicine itself."

Dunne reports that the nascent promise of the anti-aging movement, spearheaded by the American Academy of Anti-Aging Medicine, is to greatly enhance our health as we age. However, he says that is also the worst nightmare of a pharmaceutical industry bent on easing us into premature death with a plethora of profitably expensive medications. "Viewed by entrenched medical interests, the burgeoning development of anti-aging medicine is a potent threat," says Dunne.

The special report on MyLonglife.com asks:

Is HGH real
'"/>




Page: 1 2

Related medicine technology :

1. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
2. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
3. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
4. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference
5. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Rosetta Genomics to Webcast Presentation at CE Unterberg, Towbin Emerging Growth Opportunities Conference
9. GTC Biotherapeutics to Webcast Corporate Presentation at the C.E. Unterberg, Towbin Emerging Growth Life Opportunities Conference
10. Micromet, Inc. to Present at the 3rd Annual C.E. Unterberg, Towbin Emerging Growth Conference
11. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Doctors Outraged Over Growth Hormone Controversy
(Date:12/1/2008)...d today announced the initiation of a Phase 1/2 cl... JAK2 inhibitor, in leading medical centers in Aus...ibrosis (CIMF). , , The trial is designed ...in patients with CIMF and is expected to enrol up ...l assess the safety profile and evaluate the pharm...
(Date:12/1/2008)...NB-0040 at Children,s Hospital, Health Sciences Ce...wswire/ -- Enobia Pharma, an emerging Canadian bio...ics for serious bone disorders, today announced th...m for hypophosphatasia was dosed. Enobia is invest...0040 for the treatment of this rare and often crip...
(Date:12/1/2008)... , ROCHESTER, Minn., Dec. 1 /PRNewswire-USNew...se of the drug therapy etanercept ineffective in t... of the liver caused by excessive consumption of a...the December issue of Gastroenterology ( http://... Additional audio and video resources, including e...
(Date:12/1/2008)...-FirstCall/ -- Following a,Request for Proposal i...sed,third generation smallpox vaccine, Public Wo...the Canadian Department of National Defence, has a...very of IMVAMUNE(R). , The Canadian authori...ntry,s bio-preparedness programme. , The co...
Breaking Medicine Technology:S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3Pharsights Reporting and Analysis Services Business Reaches Quality Assurance Milestone 2324 1Pharsights Reporting and Analysis Services Business Reaches Quality Assurance Milestone 2324 2Pharsights Reporting and Analysis Services Business Reaches Quality Assurance Milestone 2324 3Pharsights Reporting and Analysis Services Business Reaches Quality Assurance Milestone 2324 4Human Genome Sciences to Sponsor Conference Call 2319 1Human Genome Sciences to Sponsor Conference Call 2319 2Tufts researchers update their food guide pyramid for older adults 8590 1Tufts researchers update their food guide pyramid for older adults 8590 2Tufts researchers update their food guide pyramid for older adults 8590 3Entrust Digital Signatures Help Secure More Than 18 Million U S ePassports 1682 1Entrust Digital Signatures Help Secure More Than 18 Million U S ePassports 1682 2Entrust Digital Signatures Help Secure More Than 18 Million U S ePassports 1682 3Entrust Digital Signatures Help Secure More Than 18 Million U S ePassports 1682 4
...URG, Germany, May 10th, 2007 - Antisense,Pharma, a...argeted,therapies for malignant tumors, today anno...12009 in high-grade glioma will be,presented at th...linical Oncology (ASCO), which will be held in Chi...he open-label, randomized dose-finding Phase,IIb-t...
...praisal Committee concludes that alteplase is clin... 14 May 2007 – A new clinical appraisal,publ...nical,Excellence (NICE) in the UK has recommended ... with acute ischaemic stroke, based on,its clinica...tive,care alone.1 Alteplase is marketed as Actilys...
Other Medicine Technology:2007 ASCO Annual Meeting: Clinical Results on Phase IIb-study with,AP 12009 in Anaplastic Astrocytoma selected for Poster Discussion 22007 ASCO Annual Meeting: Clinical Results on Phase IIb-study with,AP 12009 in Anaplastic Astrocytoma selected for Poster Discussion 3Actilyse (alteplase) Recommended by National Institute for Health,and Clinical Excellence for Treatment of Acute Ischaemic Stroke 2Actilyse (alteplase) Recommended by National Institute for Health,and Clinical Excellence for Treatment of Acute Ischaemic Stroke 3Actilyse (alteplase) Recommended by National Institute for Health,and Clinical Excellence for Treatment of Acute Ischaemic Stroke 4Actilyse (alteplase) Recommended by National Institute for Health,and Clinical Excellence for Treatment of Acute Ischaemic Stroke 5
(Date:12/2/2008)... Trials of tasimelteon show it could aid shift wo...ESDAY, Dec. 2 (HealthDay News) -- The experimental...aused by jet lag or night shifts, according to the...e II study included 39 people randomly assigned to... mg of tasimelteon, or a placebo. They were monito...
(Date:12/2/2008)... ORLANDO, Fla., Dec. 2 MEDai, Inc...care solutions provider, has added a new module,t...ons. The new stand-alone,module monitors a popul...delines and alerts stakeholders when there has bee...e Risk Navigator Guidelines(TM) provides,real-tim...
(Date:12/2/2008)... -Survey Reveals Nearly Half Have Skipped Medical...., Dec. 2 A new survey ...urce Center (NWHRC) highlights another troubling a...have failed to seek health care for themselves or ...ate that many women say their health has gotten wo...
(Date:12/2/2008)... MALVERN, Pa., Dec. 2 Arlington M...ket intelligence for the pharmaceutical and diagno...Janssen Pharmaceuticals, Levaquin,is the preferre... general,medical-surgical hospitals in the United...lung, sinus, skin and urinary tract infections cau...
Breaking Medicine News(10 mins):Health News:Drug Effective for Temporary Sleep Disruptions 2Health News:MEDai Evidence-Based Guideline Reporting Provides Decision Support at Point of Care 2Health News:Rising Health Costs Prompt Women to Neglect Health 2Health News:Rising Health Costs Prompt Women to Neglect Health 3Health News:Rising Health Costs Prompt Women to Neglect Health 4Health News:Levaquin is the Preferred Quinolone Among More Than Half of All General Medical-Surgical Hospitals in the United States 2
... Holtgrave, PhD, an expert on HIV prevention at th... a targeted campaign of testing and counseling aim... more effective than the mass patient screening pr...rol and Prevention (CDC). Holtgraves study is the...
...issue of CHEST, reports that children receiving an...r risk for developing asthma by age 7 than those ...oubled in children receiving antibiotics for nonre...ldren who received multiple antibiotic courses and...
... the issue of Neurology, the scientific journal of...easily distressed and have more negative emotions ...ore easygoing people. In the study, those who mos...ch as depression and anxiety were 40 percent more ...
...es re-sat their examinations Monday after a cheati...lts, an official said Monday . Lawyers hired by th...hools (CGFNS) acted as observers at examination ce...vao. Labour Secretary Arturo Brion said the gradu...
Other Medicine News:Health News:Targeted HIV Testing An Effective Way to Screen HIV Patients 2Health News:Antibiotic Use in Infants may Lead to Asthma. 2Health News:Pessimists may Develop More Memory Problems 2Health News:Philippine Nurses Re-sit Scandal-tainted Exams 2
Cold light source single outlet.
Cold light source triple outlet.
Cold light source single outlet.
The 9100 is a truly affordable 100 Watt xenon light source providing accurate color and brightness. This xenon light source is ideal for surgery centers, evaluations or general office use.
Medicine Products: